S
CRL icon

Seeyond’s Charles River Laboratories CRL Stock Holding History

Seeyond’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$433K Sell
1,989
-5
-0.3% -$1.09K 0.04% 429
2022
Q3 		$392K Sell
1,994
-110
-5% -$23.7K 0.05% 459
2022
Q2 		$450K Sell
2,104
-43
-2% -$10.5K 0.05% 462
2022
Q1 		$609K Buy
2,147
+1,022
+91% +$315K 0.06% 441
2021
Q4 		$423K Sell
1,125
-692
-38% -$269K 0.04% 497
2021
Q3 		$749K Buy
+1,817
New +$755K 0.07% 400

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Seeyond's CRL Position: Q4 2022 in Review

Seeyond reduced its Charles River Laboratories (CRL) stake by 0.25% in Q4 2022, selling an estimated $1.09K and leaving 1,989 shares worth $433K. The position accounts for 0.04% of the portfolio, ranked #429.

Seeyond first reported a position in CRL in Q3 2021 and has held it in 6 quarters since. The position peaked at $749K in Q3 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q4 2022.

  • Seeyond held 1,989 shares of Charles River Laboratories worth $433K as of Q4 2022.
  • Seeyond sold 5 Charles River Laboratories shares in Q4 2022, an estimated $1.09K.
  • Charles River Laboratories made up 0.04% of Seeyond's portfolio in Q4 2022, its #429 holding.
  • Seeyond first reported a position in Charles River Laboratories in Q3 2021 and has held it in 6 quarters since.
  • Seeyond's Charles River Laboratories position peaked at $749K in Q3 2021.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.